臨床試験

A Pivotal Study of Sensory Stimulation in Alzheimer's Disease (HOPE Study)

NCT: NCT05637801 · COMPLETED

NCT識別子NCT05637801

ステータスCOMPLETED

開始日2022-12-13

完了2026-08-17

SponsorCognito Therapeutics, Inc. (INDUSTRY)

First posted2022-12-05

Last updated2026-09-09

概要

This is a randomized, double-blind, sham-controlled pivotal study of sensory stimulation in subjects with mild to moderate AD. Up to approximately 670 subjects will be treated with either Active or Sham investigational device, Spectris™ AD, for 60 minutes daily for approximately 12 months. Efficacy will be measured using the Integrated Alzheimer's Disease Mini-Mental State Exam (MMSE) Activities of Daily Living (ADCS-ADL) Rating Scale (iADMARS).

公式ソース

ClinicalTrials.govで見る →

データはClinicalTrials.gov APIから取得しています。最新のステータスは公式記録をご確認ください。